Treatment with Ivermectin Increases the Population of Bifidobacterium in the Gut

Hazan et al., ACG 2023, Oct 2023
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 106 studies, recognized in 24 countries.
Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.
No treatment is 100% effective. Protocols combine treatments.
6,600+ studies for 220+ treatments. c19early.org
Meta-analysis
Analysis of the effect of ivermectin on the gut microbiome, showing a significant increase in Bifidobacterium.
Bifidobacterium plays a key role in the immune system, for example enhancing antibody production, facilitating the induction of regulatory T cells, modulating the immune response of macrophages, dendritic cells, and T cells, maintaining gut barrier integrity, and inhibiting harmful microbes.
Increased Bifidobacterium is associated with lower COVID-19 severity1.
Important missing comments or errors? Let us know.
Study covers probiotics and ivermectin.
Hazan et al., 22 Oct 2023, preprint, 4 authors.
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
Submit    
Post
Share
@CovidAnalysis
FAQ
Public domain CC0 1.0